Ever since the start of October when the Fed launched QE4 - or as
some still call it "Not QE" - in response to the Sept repo crisis,
figuring out the market has been pretty simple: if the Fed's balance
sheet goes up so does the S&P500, and vice versa.
The good news for traders is that for the past three months, the
Fed's balance sheet rose 11 of 12 weeks, and declined just 1 of 12, and
magically, the S&P did just that as well.
However, now that the year-end repo scare is history at least until
the April 15 tax date and certainly the next year end, it's time for the
Fed to start shrinking its balance sheet, mostly by allowing existing
term repo operations to expire without being rolled over. Conveniently,
the FOMC Minutes released moments ago provided the Fed's own big picture
take on when the massive liquidity injection since mid-September, which
expanded the Fed's balance sheet by $415BN in three and a half
months...
c
... with the Fed pointing out its "expectations to gradually
transition away from active repo operations [in 2020] as Treasury bill
purchases supply a larger base of reserves" and specifically, "the calendar of repo operations starting in mid-January could reflect a gradual reduction in active repo operations."
None of this is new, and it has almost become conventional wisdom
that when the Fed starts draining liquidity, the market impact will be
the polar opposite of what happened when it was injecting liquidity:
i.e., stocks will drop.
So with the Fed highlighting mid-January as the period when the
liquidity injection goes into reverse, here is some more details on just
which dates will be critical: as Curvature's Scott Skyrm points out,
these will be the days when the Fed's term repos maturing over the next
few weeks, supposedly without being rolled into further term repos, or
as he puts it, "during January, it will be interesting to see how the market reacts to the term RP ops maturing:" FEDは1月半ばに流動性注入が反転することを強調している、ここに示すのはそのなかでも重要な日付だ:Curvature社の Scott Skyrmが指摘するものだ、今後数週でFEDのterm reposが満期を迎えるだろう、term repoの繰延は無いと仮定している、彼の言によると「1月中に、term repo満期に市場がどう反応するか興味深いところだ:」
$25 billion leaves the market on Monday,
月曜には$25Bが市場から引き去られる、
$28.8 billion on Tuesday,
火曜には$28.8Bが引き去られる、
$18 billion next Friday, etc.
金曜には$18Bが引きさられる、というぐあいだ。
Of course, perhaps "interesting" is not the
right word, because it is clear that if liquidity is drained without a
matching injection, the market reaction will be anything but favorable.
That said, the Fed still has more term Repo ops scheduled to correspond
with those term roll-off dates, with at least three more term RP ops of
up to $35 billion scheduled in January. Whether or not banks decide to
use these to roll existing maturing term repos will determine if the
liquidity cliff starts hitting next week, or 3-4 weeks later. Finally,
it will also depend on whether the Fed decides that it had overinjected
the market with liquidity, and if it announces even more scheduled term
repos in February and onward.
当然のことだが、たぶん「興味深い」という言葉は適当ではない、というのも当分の注入なしに流動性が引き去られるのは明らかで、市場の反応は決して好感を持つものではないだろう。ということは、FEDは1月にまださらに term repoの満期を控えている。商業銀行が既存term repoの満期を繰延するかどうかで来週または3,4週後に流動性の崖が始まるかどうかが決まる。最終的には、FEDが市場に流動性を過剰注入するかどうかにかかっているだろう、そして2月以降のterm repoのさらなる対応スケジュール開示に依存する。
For now, however, here is a visual calendar of when some of the key December term repos mature over the next few days:
多量のオピオイドを米国に送り込み、米国で深刻な麻薬中毒問題を引き起こしています。現代版「阿片戦争」です。あのトヨタ初の女性取締役もオピオイド中毒で逮捕解任されましたよね。 US Is Dependent On China For Almost 80% Of Its Medicine by Tyler Durden Fri, 05/31/2019 - 12:55 Experts are warning that the U.S. has become way too reliant on China for all our medicine , our pain killers, antibiotics, vitamins, aspirin and many cancer treatment medicine. 専門家はこう警告する、米国はすべての医薬品、痛み止め、抗生物質、ビタミン、アスピリン、各種抗がん剤で、中国依存度が高すぎる。 Fox Business reports that according to FDA estimates at least 80 percent of active ingredients found in all of America’s medicine come from abroad, primarily from China . And it’s not just the ingredients, China wants to become the world’s dominant generic drug maker. So far Chinese companies are making generic for everything from high blood pressure to chemotherapy drugs. 90 percent of America’s prescriptions a...
先週の記事です。最後の2段落だけ訳をいれておきます。 Gold’s Peculiar Surge Adam Hamilton February 21, 2020 3246 Words Gold is enjoying an awesome week, surging back above $1600 for the first time in nearly 7 years! That big round psychologically-heavy level is really catching traders’ attention, great improving sentiment. Yet this recent gold surge has proven peculiar. Unlike normal rallies, the buying driving this one largely hasn’t come from gold’s usual primary drivers. The stealth buying behind this surge may impair its staying power. This Tuesday gold surged 1.2% higher to close near $1602. It hadn’t crested $1600 on close since way back in late March 2013 fully 6.9 years ago! Long-time gold traders shudder at the dark spring which followed. Within less than several weeks after that last $1600+ close, gold plummeted 16.2%. Most of that came in ...
What Could Go Wrong? The Fed's Warns On Corporate Debt by Tyler Durden Thu, 05/09/2019 - 11:44 Authored by Lance Roberts via RealInvestmentAdvice.com, “So, if the housing market isn’t going to affect the economy, and low interest rates are now a permanent fixture in our society, and there is NO risk in doing anything because we can financially engineer our way out it – then why are all these companies building up departments betting on what could be the biggest crash the world has ever seen? What is more evident is what isn’t being said. Banks aren’t saying “we are gearing up just in case something bad happens.” Quite the contrary – they are gearing up for WHEN it happens. When the turn does come, it will be unlike anything we have ever seen before. The scale of it could be considerable because of the size of some...